Dr. Teresa Tarragó
Co-Founder & Chief Executive Officer (CEO)
Dr. Tarragó has a PhD in Molecular Biology from the University of Barcelona. She has solid expertise in drug discovery, gained during 15 years spent conducting several research lines on proteases and protease inhibitors at the Spanish National Research Council (CSIC) and IRB Barcelona. She has experience in managing internationally-funded research projects, as well as directing joint undertakings with biotech companies. She has published over 40 papers and two books, and she holds four patents. In addition to her scientific qualifications, she holds an Executive MBA (ESADE) and has participated in entrepreneurship programmes, including “Ignite” at Cambridge Judge Business School and “BioEmprendedor XXI” (Barcelona).
Dr. Roger Prades
Chief Scientific Officer (CSO)
Dr. Prades has a PhD in Chemistry from the University of Barcelona and an Executive Master’s Degree in Innovation from the Industrial Organization School (EOI). He has expertise in peptide synthesis and ADME drug profiling, particularly in determining the capacity of compounds to cross the Blood-Brain Barrier (BBB) in several in vitro models. During his pre-doctoral training period at IRB Barcelona, he spent a 6-month internship at Department of Diagnostic Radiology at the Yale School of Medicine (USA). He has published nine papers in international peer-reviewed journals and holds three patents.